Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery
Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...
Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery
New molecule may block melanoma growth
Lack of melanin precursor DOPA may lead to melanoma in people with lighter skin
Viewing prior dermopathology diagnoses skews second opinions
Melanoma rates rising in Canada
Fish intake linked to higher risk of melanoma
Many melanomas found by screening may not be harmful
Potential blood test for melanoma diagnosis, prognosis